Diabetic microangiopathy: Impact of impaired cerebral vasoreactivity and delayed angiogenesis after permanent middle cerebral artery occlusion on stroke damage and cerebral repair in mice

Diabetes

Volumn 64, Issue 3, 2015, Pages 999-1010

  Poittevin, Marine ^a   Bonnin, Philippe ^a,b   Pimpie, Cynthia ^a   Rivière, Léa ^a   Sebrié, Catherine ^c   Dohan, Anthony ^a   Pocard, Marc ^a   Charriaut Marlangue, Christiane ^a   Kubis, Nathalie ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; KI 67 ANTIGEN; MESSENGER RNA; NEURON SPECIFIC NUCLEAR PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OCCLUDIN; PLATELET DERIVED GROWTH FACTOR B; PROTEIN ZO1; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; ANG2 PROTEIN, MOUSE; PANCREATIC RIBONUCLEASE; TJP1 PROTEIN, MOUSE;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BLOOD BRAIN BARRIER; BODY WEIGHT; BRAIN INFARCTION SIZE; BRAIN MICROCIRCULATION; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENDOTHELIUM CELL; EXPERIMENTAL CEREBRAL ISCHEMIA; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEAN ARTERIAL PRESSURE; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; TUNEL ASSAY; ANIMAL; BRAIN ISCHEMIA; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DIABETIC ANGIOPATHY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; DIABETIC ANGIOPATHIES; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; RIBONUCLEASE, PANCREATIC; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84928213223     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0759     Document Type: Article

References (45)

1. Mankovsky BN, Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev 2004;20:268-287
2. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-2581
3. Last D, Alsop DC, Abduljalil AM, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007;30:1193-1199
4. Bonnin P, Leger PL, Deroide N, et al. Impact of intracranial blood-flow redistribution on stroke size during ischemia-reperfusion in 7-day-old rats. J Neurosci Methods 2011;198:103-109
5. Bonnin P, Leger PL, Villapol S, et al. Dual action of NO synthases on blood flow and infarct volume consecutive to neonatal focal cerebral ischemia. Exp Neurol 2012;236:50-57
6. Nih LR, Deroide N, Leré-Déan C, et al. Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell co-administration. Eur J Neurosci 2012;35:1208-1217
7. Poittevin M, Deroide N, Azibani F, et al. Glatiramer acetate administration does not reduce damage after cerebral ischemia in mice. J Neuroimmunol 2013; 254:55-62
8. Haddad M, Beray-Berthat V, Coqueran B, et al. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice. Eur J Pharmacol 2008;588:52-57
9. Porter KE, Riches K. The vascular smooth muscle cell: a therapeutic target in type 2 diabetes? Clin Sci (Lond) 2013;125:167-182
10. Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 2003;55:271-324
11. Nozaki K, Finklestein SP, Beal MF. Delayed administration of basic fibroblast growth factor protects against N-methyl-D-aspartate neurotoxicity in neonatal rats. Eur J Pharmacol 1993;232:295-297
12. Andresen J, Shafi NI, Bryan RM Jr. Endothelial influences on cerebrovascular tone. J Appl Physiol (1985) 2006;100:318-327
13. Najarian T, Marrache AM, Dumont I, et al. Prolonged hypercapnia-evoked cerebral hyperemia via K(+) channel-and prostaglandin E(2)-dependent endothelial nitric oxide synthase induction. Circ Res 2000;87:1149-1156
14. Wang Q, Pelligrino DA, Koenig HM, Albrecht RF. The role of endothelium and nitric oxide in rat pial arteriolar dilatory responses to CO2 in vivo. J Cereb Blood Flow Metab 1994;14:944-951
15. Ma J, Meng W, Ayata C, Huang PL, Fishman MC, Moskowitz MA. L-NNAsensitive regional cerebral blood flow augmentation during hypercapnia in type III NOS mutant mice. Am J Physiol 1996;271:H1717-H1719
16. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000;130:963-974
17. Koláćek M, Muchová J, Vranková S, et al. Effect of natural polyphenols, pycnogenol on superoxide dismutase and nitric oxide synthase in diabetic rats. Prague Med Rep 2010;111:279-288
18. Cabou C, Cani PD, Campistron G, et al. Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes. Diabetes 2007;56:2872-2877
19. Mayhan WG, Arrick DM, Patel KP, Sun H. Exercise training normalizes impaired NOS-dependent responses of cerebral arterioles in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2011;300:H1013-H1020
20. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [published correction appears in Nature 1999;400:792]. Nature 1999;399:597-601
21. Li Q, Atochin D, Kashiwagi S, et al. Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size. Stroke 2013;44:3183-3188
22. Zhou L, Zhu DY. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009;20:223-230
23. Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP. Angiographic assessment of pial collaterals as a prognostic indicator following intraarterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26: 1789-1797
24. Charriaut-Marlangue C, Bonnin P, Pham H, et al. Nitric oxide signaling in the brain: a new target for inhaled nitric oxide? Ann Neurol 2013;73:442-448
25. Salinet AS, Robinson TG, Panerai RB. Cerebral blood flow response to neural activation after acute ischemic stroke: a failure of myogenic regulation? J Neurol 2013;260:2588-2595
26. Cui X, Chopp M, Zacharek A, Ye X, Roberts C, Chen J. Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol Dis 2011;43:285-292
27. Ergul A, Elgebaly MM, Middlemore ML, et al. Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol 2007;7:33
28. Prakash R, Somanath PR, El-Remessy AB, et al. Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes 2012;61:1533-1542
29. Prakash R, Johnson M, Fagan SC, Ergul A. Cerebral neovascularization and remodeling patterns in two different models of type 2 diabetes. PLoS ONE 2013; 8:e56264
30. Shoji T, Koyama H, Morioka T, et al. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes 2006; 55:2245-2255
31. Hayashi T, Noshita N, Sugawara T, Chan PH. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 2003;23:166-180
32. Tamarat R, Silvestre JS, Kubis N, et al. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension 2002;39:830-835
33. Kuntz M, Mysiorek C, Pétrault O, et al. Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo/in vitro study. J Cereb Blood Flow Metab 2014;34:95-107
34. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011;17:796-808
35. Dinel AL, André C, Aubert A, Ferreira G, Layé S, Castanon N. Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS ONE 2011;6:e24325
36. Demiot C, Tartas M, Fromy B, Abraham P, Saumet JL, Sigaudo-Roussel D. Aldose reductase pathway inhibition improved vascular and C-fiber functions, allowing for pressure-induced vasodilation restoration during severe diabetic neuropathy. Diabetes 2006;55:1478-1483
37. Jeong JO, Kim MO, Kim H, et al. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 2009;119:699-708
38. Dyck PJ, Hansen S, Karnes J, et al. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci U S A 1985;82:2513-2517
39. Giannini C, Dyck PJ. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol 1994;36:408-415
40. Malik RA, Newrick PG, Sharma AK, et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989;32:92-102
41. Malik RA, Veves A, Masson EA, et al. Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry 1992;55:557-561
42. Britland ST, Young RJ, Sharma AK, Clarke BF. Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 1990;39:909-913
43. Ergul A, Kelly-Cobbs A, Abdalla M, Fagan SC. Cerebrovascular complications of diabetes: focus on stroke. Endocr Metab Immune Disord Drug Targets 2012;12:148-158
44. Ergul A, Li W, Elgebaly MM, Bruno A, Fagan SC. Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. Vascul Pharmacol 2009;51:44-49
45. Van Belle TL, Taylor P, von Herrath MG. Mouse models for type 1 diabetes. Drug Discov Today Dis Models 2009;6:41-45